Peer-reviewed veterinary case report
Immune cells changes in dogs with mitral valve disease
By Cimerman, Martina et al.·Published in Journal of veterinary internal medicine·2026·Small Animal Clinic·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Immune response in dogs with myxomatous mitral valve disease: insights into monocyte and lymphocyte subtypes and natural killer cells.
- Species:
- dog
Plain-English summary
A study looked at 64 dogs with myxomatous mitral valve disease (MMVD), a common heart problem, to understand how their immune system responds compared to 17 healthy dogs. The researchers found that dogs with more advanced heart failure had higher levels of certain immune cells and proteins linked to inflammation. Specifically, dogs in the later stages of heart failure had more monocytes and inflammatory markers than those in earlier stages. This suggests that inflammation plays a role in worsening heart disease in dogs.
People also search for: dog heart disease symptoms · myxomatous mitral valve disease treatment · dog heart failure immune response
Abstract
BACKGROUND: The immune response in dogs with myxomatous mitral valve disease (MMVD) is understudied. HYPOTHESIS/OBJECTIVES: Investigate the populations of monocyte subtypes, natural killer cells (NK cells), and T lymphocyte subtypes in dogs with MMVD and their relationships with selected cytokines and echocardiographic parameters at different stages of the disease and in comparison to healthy dogs. ANIMALS: Eighty-one client-owned dogs: 64 with MMVD (preclinical stage, compensated congestive heart failure [CHF], decompensated CHF) and 17 healthy dogs. METHODS: Cross-sectional study. Natural killer (NK) cells, monocyte subtypes, T lymphocyte subtypes, and B lymphocytes were identified using flow cytometry. Generalized linear models were used to compare variables between groups. Pairwise comparisons were performed using estimated marginal means with Tukey correction. P-value < .05 was considered significant. RESULTS: The percentage of monocytes was higher in dogs with compensated and decompensated CHF compared with preclinical dogs. The percentage of activated T helper lymphocytes was lower in compensated CHF compared with all other groups. No differences in percentages were found for monocyte subtypes, NK cells, cytotoxic, regulatory and double positive T lymphocytes, or B lymphocytes. Concentration of monocyte chemoattractant protein-1 was higher in the decompensated CHF compared with all other groups, and the concentration of keratinocyte chemotactic-like chemokine was higher in the decompensated CHF compared with the preclinical group. CONCLUSIONS AND CLINICAL IMPORTANCE: Higher concentrations and percentages of total monocytes and concentrations of proinflammatory cytokines in CHF suggest an inflammatory pathway in MMVD progression. Activated T helper lymphocytes may be downregulated in dogs with compensated CHF.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41742596/